Key result
Engineered human mini-hearts demonstrate intrinsic pumping function enabling non-invasive hemodynamic and inotropic assessment.
Why the study?
Engineered cardiac tissue models often fail to replicate the heart's pump function and are limited by complex fabrication and invasive characterization methods.
Population
Human pluripotent stem cell-derived cardiomyocytes and human cardiac fibroblasts
Comparison
Engineered mini-heart chamber-like model vs traditional engineered cardiac tissues
Design
Preclinical study using a novel sacrificial molding approach within a customized bioreactor
Authors
Loading...
May enable preclinical hemodynamic and drug testing; extends engineered tissue models but leaves clinical translation open.
A novel engineered human mini-heart platform successfully mimics ventricular pump function, allowing for non-invasive in vitro assessment of cardiac hemodynamics.
Ribeiro et al. (2026) studied In vitro cardiac model. Engineered chamber-like human cardiac model ('mini-heart') was evaluated on Pumping capability and hemodynamic parameters. An engineered chamber-like human cardiac model ('mini-heart') demonstrated intrinsic pumping function, enabling non-invasive assessment of hemodynamics and positive inotropic response to isoproterenol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: